Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy

Mostrar otras versiones (1)

Dexamethasone, a widely used corticosteroid, has recently been reported as the first drug to increase the survival chances of patients with severe COVID-19. Therapeutic agents, including dexamethasone, are mostly transported through the body by binding to serum albumin. Herein, we report the first s...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabalin, Ivan G., Czub, Mateusz P., Majorek, Karolina A., Brzezinski, Dariusz, Grabowski, Marek, Cooper, David R., Panasiuk, Mateusz, Chruszcz, Maksymilian, Minor, Wladek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386489/
https://www.ncbi.nlm.nih.gov/pubmed/32743572
http://dx.doi.org/10.1101/2020.07.21.212704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386489/
https://www.ncbi.nlm.nih.gov/pubmed/32743572
http://dx.doi.org/10.1101/2020.07.21.212704

Ejemplares similares